thank stand welcome west pharmaceutical service earn conference call operator instruction please advise today conference record operator instruction would like hand today conference speaker vice president investor relation please ahead vice president investor relation thank good morning welcome west first quarter conference call issue financial result morning release post investor section company website locate westpharma morning green review financial result provide update business present update full year financial guidance slide presentation accompany today call copy presentation available investor section website slide safe harbor statement statement make management call accompany presentation contain forward look statement within mean federal security statement base belief assumption current expectation estimate forecast company future result influence many factor beyond control company actual result could differ materially past result express imply forward look statement make please refer today press release disclosure make company regard risk subject include report today call management make reference financial measure include organic sale growth adjust operate profit adjust operate profit margin adjust dilute reconciliation limitation financial measure comparable financial result prepare conformity provide morning earn release turn call west president green green chief executive officer great thank good morning everyone thank join today start slide please report exceptional first quarter drive strong organic sale growth base business accelerate demand product associate high value product continue fuel increase gross operate margin together result record first quarter strength performance demonstrate ability execute market lead strategy leverage power global manufacture network rally west meet increase market demand proud member focus priority emphasize importance purpose value time turn slide highlight driver growth continue strong uptake component include envision offer crystal biologics customer seek best industry component ensure highest degree quality safety vaccine injectable medicine result strong double digit growth exclude sale continue demand growth biologics business first four month participation rate recently approve molecular entity continue strong approval either west component addition experience strong growth ready component customer seek value quality convenience wash product envision also significant growth customer look higher quality better production yield envision inspect component another highlight strong sale growth vial customer prefer compatibility sensitive molecule outstanding track record quality reliability move slide power global manufacture network continue support growth trajectory uniquely position result global operation strategy implement year enable right capability scale flexibility keep pace increase demand result recent capital investment expand manufacture capacity across high value product portfolio additional equipment validate line support highest growth area accelerate timeline capacity build within exist footprint work closely incumbent supplier installation around plant schedule first phase begin start pandemic operational expect completion second half year second phase equipment arrive back year operational evaluate additional investment third expansion phase response increase possibility booster annual vaccination require next year occur think future vaccine could likely fewer vial single dose prefilled result mean higher volume demand component compare experience today please share recent visit facility schedule fully automate line insert needle process validate line target commence commercial production customer commit order third quarter year third automate line another line schedule delivery late turn slide core value west strong corporate citizen exceed initial five year environmental social governance initiative raise higher five year goal proud continue make significant progress priority good momentum toward state reduction goal waste energy water usage continue reaffirm commitment live west value call respect drive collaboration embrace diversity inclusion workplace continue make stride area member hire level manufacture site diverse representation executive leadership west continuously look improve sustainability business rigor report continue evolve last year publish supplement later year publish supplement report incorporate standard turn provide detail financial performance chief financial officer thank good morning review number detail first look revenue profit continue strong sale growth lead strong revenue performance primarily biologics pharma generic market unit take margin growth quarter balance sheet takeaway finally provide update guidance first financial result summarize slide reconciliation measure describe slide record sale million represent organic sale growth relate revenue estimate approximately million quarter revenue include assessment component associate vaccine treatment diagnosis patient offset lower sale customer affect lower volume pandemic look slide proprietary product sale grow organically quarter high value product make proprietary product sale quarter grow double digit solid momentum across market unit throughout look performance market unit biologics market unit deliver strong double digit growth continue work many biotech biopharma customer west high value product offer generic market unit also experience strong double digit growth lead sale component pharma market unit strong double digit growth sale lead high value product include component contract manufacture single digit organic sale growth first quarter lead sale diagnostic healthcare relate injection device continue improvement gross profit record million gross profit million last year gross profit margin basis point expansion period last year improvement adjust operate profit million record quarter compare million period last year increase adjust operate profit margin basis point increase period last year finally adjust dilute grow exclude stock base compensation benefit grow approximately review growth driver revenue profit slide show contribution sale growth quarter volume contribute million percentage point growth include approximately million volume drive relate demand sale price increase contribute million percentage point growth change foreign currency exchange rate increase sale million increase percentage point look margin performance slide show consolidate gross profit margin proprietary product first quarter gross profit margin basis point margin achieve first quarter driver continue improvement proprietary product gross profit margin favorable product sell drive growth high value product production efficiency time associate certain cancel supply agreement approximately million sale price increase partially offset increase overhead inclusive compensation contract manufacture first quarter profit gross margin basis point margin achieve first quarter result improve efficiency plant utilization look balance sheet review term generate cash business slide list cash flow metric operate cash flow million first quarter increase million compare period last year increase first quarter capital spend million million higher period last year line guidance work capital million march decline slightly million cash balance march million million balance primarily share repurchase program activity offset positive operate result turn guidance slide provide high level summary full year sale expect range billion billion compare prior guidance range billion billion guidance include estimate incremental revenue approximately million estimate benefit million base current foreign exchange rate expect organic sale growth approximately expect full year adjust dilute guidance range compare prior range continue expand manufacture capacity exist site meet anticipate core growth vaccine demand keep capex guidance million million continue evaluate level need support continue growth element want bring attention review guidance estimate benefit impact approximately base current foreign currency exchange rate guidance exclude future benefit stock base compensation summarize takeaway first quarter strong line growth proprietary gross profit margin improvement growth operate profit margin growth adjust dilute growth operate free cash flow deliver line pillar execute innovate grow like turn call back green chief executive officer thank summarize slide dynamic change environment remain commit customer patient serve together focus remain within strategic pillar allow responsive leverage asset effectively support trend happen industry today work position strength believe long horizon continue organic sale growth margin expansion today ever enable customer ability support patient health take grant west product need patient across globe many case administration life save medicine market leader know west continue play integral role customer develop bring medicine market brighter future ready take question thank